A detailed history of Perceptive Advisors LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 28,057,456 shares of FOLD stock, worth $276 Million. This represents 7.83% of its overall portfolio holdings.

Number of Shares
28,057,456
Previous 28,057,456 -0.0%
Holding current value
$276 Million
Previous $278 Million 7.66%
% of portfolio
7.83%
Previous 8.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$9.97 - $14.52 $3.63 Million - $5.29 Million
364,539 Added 1.32%
28,057,456 $398 Million
Q3 2023

Nov 14, 2023

BUY
$11.78 - $13.86 $353,400 - $415,800
30,000 Added 0.11%
27,692,917 $337 Million
Q1 2023

May 15, 2023

BUY
$10.91 - $13.54 $218,200 - $270,800
20,000 Added 0.07%
27,662,917 $307 Million
Q4 2022

Feb 14, 2023

BUY
$9.89 - $12.7 $2.67 Million - $3.43 Million
270,000 Added 0.99%
27,642,917 $338 Million
Q3 2022

Nov 14, 2022

BUY
$9.82 - $12.75 $4.69 Million - $6.09 Million
477,385 Added 1.77%
27,372,917 $286 Million
Q2 2022

Aug 15, 2022

SELL
$6.23 - $11.12 $4.11 Million - $7.34 Million
-660,313 Reduced 2.4%
26,895,532 $289 Million
Q1 2022

May 16, 2022

BUY
$7.89 - $12.48 $7.86 Million - $12.4 Million
996,402 Added 3.75%
27,555,845 $261 Million
Q3 2021

Nov 15, 2021

BUY
$8.74 - $11.84 $30 Million - $40.7 Million
3,438,114 Added 14.87%
26,559,443 $254 Million
Q2 2021

Aug 16, 2021

BUY
$8.71 - $10.72 $2.26 Million - $2.79 Million
260,000 Added 1.14%
23,121,329 $223 Million
Q1 2021

May 17, 2021

SELL
$9.2 - $23.86 $20.7 Million - $53.7 Million
-2,250,719 Reduced 8.96%
22,861,329 $226 Million
Q4 2020

Feb 16, 2021

SELL
$13.47 - $24.89 $134,700 - $248,900
-10,000 Reduced 0.04%
25,112,048 $580 Million
Q3 2020

Nov 16, 2020

SELL
$12.89 - $15.89 $777,473 - $958,421
-60,316 Reduced 0.24%
25,122,048 $355 Million
Q1 2020

May 15, 2020

BUY
$6.63 - $11.16 $331,500 - $558,000
50,000 Added 0.2%
25,182,364 $233 Million
Q4 2019

Feb 14, 2020

BUY
$7.48 - $10.75 $3.91 Million - $5.62 Million
522,664 Added 2.12%
25,132,364 $245 Million
Q3 2019

Nov 14, 2019

BUY
$8.02 - $13.25 $24.9 Million - $41.1 Million
3,100,214 Added 14.41%
24,609,700 $197 Million
Q2 2019

Aug 14, 2019

SELL
$10.96 - $14.4 $1.42 Million - $1.87 Million
-130,000 Reduced 0.6%
21,509,486 $268 Million
Q1 2019

May 15, 2019

BUY
$10.04 - $13.92 $9.19 Million - $12.7 Million
915,062 Added 4.42%
21,639,486 $294 Million
Q4 2018

Feb 14, 2019

BUY
$8.38 - $13.44 $251,400 - $403,200
30,000 Added 0.14%
20,724,424 $192 Million
Q3 2018

Nov 14, 2018

BUY
$11.6 - $16.54 $7.77 Million - $11.1 Million
670,000 Added 3.35%
20,694,424 $250 Million
Q1 2018

May 15, 2018

BUY
$13.76 - $17.12 $29.4 Million - $36.6 Million
2,135,827 Added 11.94%
20,024,424 $301 Million
Q3 2017

Nov 14, 2017

BUY
$11.74 - $15.78 $210 Million - $282 Million
17,888,597
17,888,597 $270 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.76B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.